A detailed history of Aqr Capital Management LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 28,276 shares of AXSM stock, worth $2.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,276
Previous 8,330 239.45%
Holding current value
$2.28 Million
Previous $662,000 240.79%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$69.39 - $97.64 $1.38 Million - $1.95 Million
19,946 Added 239.45%
28,276 $2.26 Million
Q4 2023

Feb 14, 2024

SELL
$57.42 - $83.61 $82,168 - $119,645
-1,431 Reduced 14.66%
8,330 $662,000
Q3 2023

Nov 14, 2023

SELL
$69.25 - $82.21 $134,760 - $159,980
-1,946 Reduced 16.62%
9,761 $682,000
Q2 2023

Aug 14, 2023

BUY
$58.41 - $90.35 $168,337 - $260,388
2,882 Added 32.66%
11,707 $841,000
Q1 2023

May 15, 2023

BUY
$58.39 - $75.0 $8,641 - $11,100
148 Added 1.71%
8,825 $544,000
Q4 2022

Feb 14, 2023

SELL
$39.94 - $79.72 $124,133 - $247,769
-3,108 Reduced 26.37%
8,677 $669,000
Q3 2022

Nov 14, 2022

BUY
$36.06 - $69.85 $219,569 - $425,316
6,089 Added 106.9%
11,785 $526,000
Q2 2022

Aug 15, 2022

BUY
$21.74 - $46.75 $123,831 - $266,288
5,696 New
5,696 $218,000
Q1 2021

May 17, 2021

SELL
$55.91 - $81.44 $378,734 - $551,674
-6,774 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$66.31 - $86.52 $479,487 - $625,626
-7,231 Reduced 51.63%
6,774 $552,000
Q3 2020

Nov 16, 2020

SELL
$68.34 - $85.84 $256,275 - $321,900
-3,750 Reduced 21.12%
14,005 $998,000
Q2 2020

Aug 17, 2020

SELL
$49.87 - $98.69 $181,028 - $358,244
-3,630 Reduced 16.97%
17,755 $1.46 Million
Q1 2020

May 15, 2020

SELL
$41.2 - $101.31 $266,976 - $656,488
-6,480 Reduced 23.25%
21,385 $1.26 Million
Q4 2019

Feb 14, 2020

BUY
$16.71 - $106.24 $138,308 - $879,348
8,277 Added 42.26%
27,865 $2.88 Million
Q3 2019

Nov 14, 2019

BUY
$20.24 - $29.16 $396,461 - $571,186
19,588 New
19,588 $396,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.45B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.